The global market for fat replacers is projected to reach $5.5 billion by 2030, driven by the increasing prevalence of obesity and chronic diseases worldwide. The anti-obesity drugs market is expected to grow at a CAGR of over 23% from 2023 to 2030, reaching $14.8 billion. The global obesity market is expected to expand at a CAGR of 14.4% during the forecast period of 2024-2029, reaching $61.7 billion by the end of 2029. The North America weight management products market is projected to reach $9.64 billion by 2028.

Growing Markets in Nutrition and Obesity